---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-098405"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2026-09-09T20:20:39+00:00"
generated_at: "2026-09-09T20:21:19.906692+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pasithea shareholders approve reverse stock split up to 1:20; re-elect two directors

## Summary
- Annual meeting held Sept 9, 2026; quorum of 26,142,328 of 33,414,448 shares represented.
- Dr. Tiago Reis Marques re-elected with 18,381,039 votes for; Prof. Lawrence Steinman with 17,000,205.
- Ratified CBIZ as independent auditor for FY2026: 25,935,574 for, 199,988 against.
- Approved reverse stock split amendment (1:2 to 1:20) with 25,071,052 for, 1,053,169 against; board sets exact ratio.

## SEC filing metadata
- accession: 0001213900-26-098405
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2026-09-09T20:20:39+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390026098405/0001213900-26-098405-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390026098405/ea0304934-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-098405
- JSON: https://secwatch.observer/filing/0001213900-26-098405.json
- Plain text: https://secwatch.observer/filing/0001213900-26-098405.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.